首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Potent and Metabolically Stable Agonists for Protease-Activated Receptor-2:Evaluation of Activity in Multiple Assay Systems in Vitro and in Vivo
【24h】

Potent and Metabolically Stable Agonists for Protease-Activated Receptor-2:Evaluation of Activity in Multiple Assay Systems in Vitro and in Vivo

机译:蛋白酶激活受体2的有效和代谢稳定的激动剂:体内和体外多个测定系统中活性的评估

获取原文
获取原文并翻译 | 示例
           

摘要

To develop potent and metabolically stable agonists for pro-tease-activated receptor-2 (PAR-2),we prepared 2-furoylated (2f) derivatives of native PAR-2-activating peptides,2f-LIGKV-OH,2f-LIGRL-OH,2f-LIGKV-NH_2,and 2f-LIGRL-NH_2,and systematically evaluated their activity in PAR-2-responsive cell lines and tissues.In both HCT-15 cells and NCTC2544 cells overexpressing PAR-2,all furoylated peptides increased cyto-solic Ca~(2+) levels with a greater potency than the corresponding native peptides,although a similar maximum response was recorded.The absolute potency of each peptide was greater in NCTC2544,possibly due to a higher level of receptor expression.Furthermore,the difference in potency between the 2-furoylated peptides and the native peptides was enhanced when evaluated in the rat superior mesenteric artery and further increased when measuring PAR-2-mediated salivation in ddY mice in vivo.The potency of 2f-LIGRL-NH_2,the most powerfulpeptide,relative to SLIGKV-OH,was about 100 in the cultured cell Ca~(2+) signaling assays,517 in the vasorelaxation assay,and 1100 in the salivation assay.Amastatin,an aminopeptidase inhibitor,augmented salivation caused by native peptides,but not furoylated peptides.The PAR-2-activating peptides,including the furoylated derivatives,also produced salivation in the wild-type C57BU6 mice,but not the PAR-2-deficient mice.Our data thus demonstrate that substitution of the N-terminal serine with a furoyl group in native PAR-2-activating peptides dramatically enhances the agonistic activity and decreases degradation by aminopeptidase,leading to development of 2f-LIGRL-NH_2,the most potent peptide.Furthermore,the data from PAR-2-deficient mice provide ultimate evidence for involvement of PAR-2 in salivation and the selective nature of the 2-furoylated peptides.
机译:为开发蛋白酶激活受体2(PAR-2)的有效且代谢稳定的激动剂,我们制备了天然PAR-2-激活肽的2-呋喃基化(2f)衍生物,2f-LIGKV-OH,2f-LIGRL- OH,2f-LIGKV-NH_2和2f-LIGRL-NH_2,并系统地评估了它们在PAR-2应答细胞系和组织中的活性。在过表达PAR-2的HCT-15细胞和NCTC2544细胞中,所有糠醛化肽均增加了细胞-solic Ca〜(2+)水平比相应的天然肽具有更高的效价,尽管记录了相似的最大响应。NCTC2544中每种肽的绝对效价更高,这可能是由于受体表达水平较高所致。当在大鼠肠系膜上动脉中评估时,2-糠醛化肽与天然肽之间的效力差异增加,而在ddY小鼠体内测量PAR-2介导的唾液分泌时,该差异进一步增加。2f-LIGRL-NH_2,相对于SLIGKV-OH,最强大的肽是100 in培养的细胞Ca〜(2+)信号传导测定,血管舒张测定中的517,唾液酸化中的1100.阿马他汀(一种氨肽酶抑制剂)增强了由天然肽而非呋喃化肽引起的唾液分泌。PAR-2活化肽包括呋喃化衍生物在内的野生型C57BU6小鼠也产生唾液分泌,而PAR-2缺乏小鼠则没有。我们的数据因此证明了天然PAR-2激活中呋喃酰基取代了N-末端丝氨酸。肽显着增强了激动活性并减少了氨肽酶的降解,从而导致了最有效的肽2f-LIGRL-NH_2的形成。此外,来自PAR-2缺陷小鼠的数据提供了PAR-2参与唾液分泌和分泌的最终证据。 2-糠基化肽的选择性性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号